Cited by 9Thyroid and Parathyroid SurgeryThyroid Disorders and TreatmentsThyroid Cancer Diagnosis and Treatment

Comparison of dosing schemes for thyroid hormone replacement therapy after thyroidectomy

Valenzuela, Fabiola, Berrios, Luis, Robledo, Candace A., Snyder, Samuel, Barney, Javier Malcolm, Reinhart, Henry, Romero Arenas, Minerva A.·2021·Journal of Surgical Research

Abstract

Background Current thyroid hormone replacement therapy (THRT) is built on weight-based standard calculation of dose. A novel Poisson regression model, which accounts for seven clinical variables, was recently proposed to improve accuracy of THRT. We aimed to compare the accuracy of estimated THRT dose to reach euthyroid and the difference in predicted dose between the Poisson (scheme A) and the weight-based standard (scheme B) in patients following total thyroidectomy for benign disease.Methods We retrospectively reviewed medical record of patients who underwent total or completion thyroidectomy for benign disease at a single institution between 2011 and 2019. The THRT dose was calculated using both schemes. We compared the difference between calculated THRT and prediction rates for optimal THRT dosing needed to achieve a euthyroid state between dosing schemes. Patients were evaluated for achieving euthyroid state, defined as TSH 0.45-4.5 mIU/L. We also compared dosing error rates (> 25 mcg over- and underdosing) between schemes. Prediction rates were compared by BMI tertiles to account for the effect of BMI extremes in achieving euthyroid state. The difference in predicted dose between schemes was calculated in both the total sample size and patients that met euthyroid. A measure of agreement, Kappa, was used to estimate agreement between dosing schemes.Results A total of 406 patients underwent total thyroidectomy for benign disease, with 184 having sufficient follow up data confirming euthyroid state. Of the 184 patients, 85.9% (n = 158) were women, 81% (n = 149) were Hispanic, and 56.5% (n = 104) were obese with a median BMI of 30.8 kg/m2. Scheme A resulted in a higher, but not statistically significant, accuracy rate (A: 60.3%, n = 111 versus B: 53.8%, n = 99; P = 0.21). Overdosing errors were lower with Scheme A (A:17.9% versus B: 32.1%; P = 0.0025) and less extreme > 25 µg (A: 17.9% versus B: 26.1%; P = 0.08). A trend in improved accuracy in patients with a BMI > 35 kg/m2 was noted (A: 46.9% versus B: 34.4%; P = 0.20). Scheme A also resulted in less overdosing errors in obese patients compared to Scheme B (A: 19.2% versus 45.2%; P = 0.0006). The average difference in predicted dose between schemes was an entire dose difference, mean of 16.0 µg and 15.8 µg for the total and euthyroid samples respectively. Furthermore, for the majority of patients the predicted dose did not match between the two dosing schemes for total and euthyroid samples, 76% (n = 311) and 76% (n = 141) respectively. In patients that achieved euthyroid, agreement between dosing schemes was low to moderate (Kappa = 0.360).Conclusions Lower rates of overdosing were found for scheme A, particularly with obese patients. No statistically significant differences in predicted THRT dose was observed between schemes. The difference in predicted dose between schemes was on average 15 ug, correlating with an entire dose. The consideration of clinical variables other than weight (scheme A) when determining optimal THRT dosing may be of importance to prevent overdoses, with particular clinical relevance in patients with higher BMIs.

Integrity signals

Registry

Crossref · 10.1016/j.jss.2021.03.016

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Valenzuela, F., Berrios, L., Robledo, C. A., Snyder, S., Barney, J. M., Reinhart, H., & Romero Arenas, M. A.
Affiliations
  • The University of Texas Rio Grande Valley (US)
  • Doctors Hospital at Renaissance (US)
Venue
Journal of Surgical Research
Publisher
Elsevier BV
Published
2021-08
Volume
264
Pages
316-320
ISSN
0022-4804 (ISSN-L)
OpenAlex
W3156478362
Cited by
9
References
12
Citations by year
2025: 5 · 2023: 3 · 2022: 1
FWCI
0.94
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Surgical Research (publishedVersion)
  • PubMed (publishedVersion)
  • ScholarWorks @ UTRGV (The University of Texas Rio Grande Valley) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
thyroid hormone replacement, total thyroidectomy, euthyroidism, dose accuracy, dosing errors, body mass index, obesity, benign thyroid disease, thyroid-stimulating hormone, hyperthyroidism, hypothyroidism, completion thyroidectomy, kappa agreement
MeSH terms
Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Body Weight, Dose-Response Relationship, Drug, Female, Humans, Hypothyroidism, Male, Medication Errors, Middle Aged, Obesity, Retrospective Studies, Thyroid Gland, Thyroid Neoplasms, Thyroidectomy, Thyroxine, Poisson Distribution, Hormone Replacement Therapy, Drug Dosage Calculations, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review